#USA #Avid Bioservices #Tustin #Chief People Officer #Maria Ebro Andreasen

Avid Bioservices Appoints New Chief People Officer

Avid Bioservices, a notable contract development and manufacturing organization (CDMO) in the biotechnology sector, proudly announces the appointment of Maria Ebro Andreasen as its new Chief People Officer. This strategic hire aims to bolster the company's ongoing growth and enhance its talent development strategy amid an ever-expanding operational scope.

The recent appointment coincides with Avid's plan to broaden its workforce as demand for its services continues to escalate. By enhancing its operational workforce, Avid seeks to maintain the premium quality standards and collaborative environment that define its corporate culture. Kenneth Bilenberg, the President and CEO of Avid Bioservices, underscored the focus on people and purpose, remarking, "As we endeavor to help double patients in the future with innovative medicines, it’s crucial we grow intentionally, bringing in exceptional talent and preserving the culture and expertise trusted by our clients. Maria brings the leadership that we need to accomplish these goals."

Maria Ebro Andreasen will spearhead several key HR initiatives aimed at ensuring Avid Bioservices meets its ambitious growth targets:

• - Enhancing Recruitment Processes: Avid aims to refine its talent acquisition strategies to attract the best professionals in the industry.
• - Expanding University and Internship Programs: Recognizing the importance of cultivating relationships with educational institutions, Avid is focusing on developing strong partnerships and internship opportunities, particularly in Southern California. This will create a steady pipeline of fresh talent ready to enter the workforce in the biotechnology sector.
• - Strengthening Employee Development and Retention: Andreasen will be tasked with implementing strategies that will foster employee growth, morale, and long-term engagement.
• - Supporting Organizational Growth: These initiatives will align with Avid's strategic direction while maintaining its culture, which is vital for the successful retention of talent.

"What drew me to Avid was the clear connection between its people, purpose, and the patients it serves," says Maria Ebro Andreasen. "Investing in our people is always the best investment we can make. By developing an environment and culture where everyone can learn, grow, and thrive, we not only unlock their potential but also pave the way for helping even more patients. I am excited to join Avid's talented team and help advance our ambitious path ahead."

Avid Bioservices' commitment to investing in talent is indicative of its broader objective to support clients through every stage of the development process. As the industry evolves and clients’ programs grow, Avid’s teams will grow alongside them, ensuring sustained success and innovation across the board.

About Avid Bioservices

Avid Bioservices stands as a leading global contract development and manufacturing organization (CDMO) specializing in mammalian cell culture production. Headquartered in the U.S., Avid boasts an impeccable track record with the FDA, earning the trust of innovative biopharmaceutical companies worldwide. Known for its agility, high quality, and capacity to navigate complex global regulatory environments, Avid supports both emerging biotech firms and large pharmaceutical companies. The company offers comprehensive solutions from development to commercial supply, ensuring reliability and excellence.

Avid by the Numbers:

• - Over 600 batches manufactured.
• - More than 275 commercial batches delivered globally.
• - Over 7 commercially approved products.
• - 10 pre-approval/licensing inspections successfully completed by major regulatory agencies.

For more information about Avid Bioservices and its range of services, please visit avidbio.com.